Immuneering Corporation (IMRX) at a glance

Immuneering Corporation (IMRX) is a micro-cap Healthcare company. It trades at $5.01, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 56/100 overall. Its strongest dimension is Safety (94/100) and its weakest is Momentum (26/100). It is a relatively defensive holding with below-market volatility.

Price

$5.02

Market cap

$271.1M

P/E ratio

n/a

Dividend yield

None

Beta

0.38

52-week range

$3.86 to $10.08